1. Home
  2. YMAB vs SBT Comparison

YMAB vs SBT Comparison

Compare YMAB & SBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YMAB
  • SBT
  • Stock Information
  • Founded
  • YMAB 2015
  • SBT 1984
  • Country
  • YMAB United States
  • SBT United States
  • Employees
  • YMAB N/A
  • SBT N/A
  • Industry
  • YMAB Biotechnology: Pharmaceutical Preparations
  • SBT Savings Institutions
  • Sector
  • YMAB Health Care
  • SBT Finance
  • Exchange
  • YMAB Nasdaq
  • SBT Nasdaq
  • Market Cap
  • YMAB 270.5M
  • SBT 249.0M
  • IPO Year
  • YMAB 2018
  • SBT 2017
  • Fundamental
  • Price
  • YMAB $5.72
  • SBT $4.61
  • Analyst Decision
  • YMAB Strong Buy
  • SBT
  • Analyst Count
  • YMAB 10
  • SBT 0
  • Target Price
  • YMAB $21.10
  • SBT N/A
  • AVG Volume (30 Days)
  • YMAB 542.6K
  • SBT 17.2K
  • Earning Date
  • YMAB 03-04-2025
  • SBT 01-30-2025
  • Dividend Yield
  • YMAB N/A
  • SBT N/A
  • EPS Growth
  • YMAB N/A
  • SBT N/A
  • EPS
  • YMAB N/A
  • SBT 0.04
  • Revenue
  • YMAB $84,553,000.00
  • SBT $66,063,000.00
  • Revenue This Year
  • YMAB $6.41
  • SBT N/A
  • Revenue Next Year
  • YMAB $18.15
  • SBT N/A
  • P/E Ratio
  • YMAB N/A
  • SBT $115.25
  • Revenue Growth
  • YMAB N/A
  • SBT N/A
  • 52 Week Low
  • YMAB $5.60
  • SBT $4.40
  • 52 Week High
  • YMAB $20.90
  • SBT $5.97
  • Technical
  • Relative Strength Index (RSI)
  • YMAB 35.08
  • SBT 39.41
  • Support Level
  • YMAB $5.60
  • SBT $4.67
  • Resistance Level
  • YMAB $6.57
  • SBT $4.75
  • Average True Range (ATR)
  • YMAB 0.38
  • SBT 0.07
  • MACD
  • YMAB 0.10
  • SBT -0.01
  • Stochastic Oscillator
  • YMAB 11.43
  • SBT 0.00

About YMAB Y-mAbs Therapeutics Inc.

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.

About SBT Sterling Bancorp Inc.

Sterling Bancorp Inc is a unitary thrift holding company. Its primary business is the operation of its wholly-owned subsidiary, Sterling Bank, through which it offers a range of loan products to the residential and commercial markets, as well as retail banking services. The products and services offered by the bank include saving and current accounts, demand and term deposits, payment cards, trade finance, fund transfer, treasury and cash management. It provides services such as construction loans, residential real estate, commercial real estate, commercial lines of credit and other consumer loans.

Share on Social Networks: